Current
$1.35B
5-Year Average
$141.92M
All-Time High
$5.88B
All-Time Low
$0.00
Market cap daily chart for SELLAS Life Sciences Group (SLS)
Jun 14, 2021 – Jun 12, 2026 · 1,256 trading days
Market Cap growth chart for SELLAS Life Sciences Group (SLS) from 2008 to 2026
Latest: +228.5%
Market Cap history table for SELLAS Life Sciences Group (SLS) from 2008 to 2026
| 2026 | $1.35B | +228.5% | +$939.41M | ||
| 2025 | $411.12M | +545.9% | +$347.47M | ||
| 2024 | $63.65M | +116.2% | +$34.21M | ||
| 2023 | $29.44M | -35.7% | −$16.33M | ||
| 2022 | $45.77M | -46.5% | −$39.84M | ||
| 2021 | $85.61M | +84.7% | +$39.26M | ||
| 2020 | $46.35M | +321.2% | +$35.34M | ||
| 2019 | $11.00M | -31.6% | −$5.08M | ||
| 2018 | $16.08M | -11.9% | −$2.17M | ||
| 2017 | $18.25M | -66.9% | −$36.88M | ||
| 2016 | $55.14M | -93.7% | −$826.86M | ||
| 2015 | $882.00M | -45.6% | −$740.24M | ||
| 2014 | $1.62B | -59.7% | −$2.40B | ||
| 2013 | $4.03B | +368.1% | +$3.17B | ||
| 2012 | $860.07M | +459.7% | +$706.40M | ||
| 2011 | $153.68M | -64.0% | −$272.64M | ||
| 2010 | $426.32M | -36.2% | −$241.44M | ||
| 2009 | $667.76M | -6.1% | −$43.28M | ||
| 2008 | $711.04M | — | — |
- 2026$1.35B+228.5%
- 2025$411.12M+545.9%
- 2024$63.65M+116.2%
- 2023$29.44M-35.7%
- 2022$45.77M-46.5%
- 2021$85.61M+84.7%
- 2020$46.35M+321.2%
- 2019$11.00M-31.6%
- 2018$16.08M-11.9%
- 2017$18.25M-66.9%
- 2016$55.14M-93.7%
- 2015$882.00M-45.6%
- 2014$1.62B-59.7%
- 2013$4.03B+368.1%
- 2012$860.07M+459.7%
- 2011$153.68M-64.0%
- 2010$426.32M-36.2%
- 2009$667.76M-6.1%
- 2008$711.04M—
Market Cap values are taken from SELLAS Life Sciences Group's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at SELLAS Life Sciences Group (SLS)
According to SELLAS Life Sciences Group's latest reported financial statements, the company's latest reported market cap is $729.60M. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2026, SELLAS Life Sciences Group (SLS) market cap totalled $1.35B – surged 228.5% year-over-year.
SELLAS Life Sciences Group market cap compound annual growth for the 2021–2026 (5 years) window is +73.6%, sustaining 3 straight years of year-over-year growth.
SELLAS Life Sciences Group market cap peaked at $4.03B in 2013; the latest annual figure is $1.35B in 2026 (66.5% below peak).
2013 marks the peak market cap at $4.03B, with the historical low of $11.00M recorded in 2019.
SELLAS Life Sciences Group Market Cap by Year
SELLAS Life Sciences Group Market Cap 2026: $1.35B
In 2026, SELLAS Life Sciences Group reported market cap of $1.35B, surged 228.5% from 2025.
SELLAS Life Sciences Group Market Cap 2025: $411.12M
SELLAS Life Sciences Group market cap in 2025 was $411.12M, surged 545.9% from 2024.
SELLAS Life Sciences Group Market Cap 2024: $63.65M
2024's market cap for SELLAS Life Sciences Group came in at $63.65M, surged 116.2% from 2023.
SELLAS Life Sciences Group Market Cap 2023: $29.44M
SELLAS Life Sciences Group posted market cap of $29.44M in 2023, plunged 35.7% below 2022.
SELLAS Life Sciences Group Market Cap 2022: $45.77M
SELLAS Life Sciences Group market cap in 2022 was $45.77M.
See more financial history for SELLAS Life Sciences Group (SLS).
Sector peers by Market Cap
Healthcare peers of SELLAS Life Sciences Group (SLS), ranked by their latest market cap
| $1.07T | |
| $579.83B | |
| $402.35B | |
| $371.00B | |
| $294.03B | |
| $277.22B | |
| $194.99B | |
| $191.70B |
- $1.07T
- $579.83B
- $402.35B
- $371.00B
- $294.03B
- $277.22B
- $194.99B
- $191.70B
Frequently asked questions
SELLAS Life Sciences Group (SLS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation